Placeholder Banner

BIO Statement on U.S.-China Comprehensive Economic Dialogue

May 12, 2017

“The Biotechnology Innovation Organization welcomes news of the U.S.-China agreement on initial results of the 100-day Action Plan of the U.S.-China Comprehensive Economic Dialogue,” said Joseph Damond, Executive Vice President for International Affairs.  “The agreement marks an important first step in the 100-day plan and towards broader engagement through the newly formed U.S.-China Comprehensive Economic Dialogue.” 

“Considering the history of this issue, the ultimate test of success will be for China to follow its process and quickly approve the eight pending biotechnology applications and establish a synchronized, timely and predictable process going forward,” added Damond.  “BIO will continue to engage through this process to monitor the implementation of the agreement.”  

Discover More
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on reports of the retirement of Richard Pazdur from the US FDA.“Dr. Pazdur has dedicated decades of his career…
WASHINGTON, D.C. – The Biotechnology Innovation Organization (BIO) released the following statement on today’s passage of the Mikaela Naylon Give Kids a Chance Act in the House of Representatives.“The unanimous House passage of the Mikaela Naylon…